With the holiday season upon us, what better time for a few cautionary notes from Trace about the holidays that rack up the lion’s share of death alongside the fun? —> Read More Here
Revealed in Seoul, and called EyeCan+, the portable box allows disabled people to write documents or browse the internet by blinking and moving their eyes. —> Read More Here
Canadian phone firm BlackBerry is offering to pay iPhone users up to $600 if they swap to its handsets. —> Read More Here
The Regeneration Generation: A Conversation With Bob Hariri, Vice-Chairman and Co-Founder of Human Longevity Inc.
Bob Hariri, M.D., Ph.D., is the vice chairman of Human Longevity Inc. (HLI), a genomics and cell-therapy diagnostics and therapeutics company he co-founded in 2013 with Craig Venter and Peter Diamandis, which is focused on extending the healthy, high-performance human lifespan. Utilizing technological advancements in genomics, bioinformatics, computing and cell therapy, HLI plans to develop therapeutic solutions to some of the most complex yet actionable diseases, such as cancer, heart disease and dementia. A recipient of the Thomas Alva Edison Award in 2007 and 2011, the former CEO of Celgene Cellular Therapeutics, and one of the pioneers of the global cell-therapy industry, Bob recently sat down with me to discuss his current work on the frontiers of aging and cellular science.
You’ve formed one of the most provocative and promising companies working in the cellular sciences. How did you get together with Craig Venter and Peter Diamandis of the X PRIZE?
I am very fortunate to have two remarkable visionary friends in Craig and Peter. I have admired the work that Craig has done in the broad landscape of genomics and synthetic biology and have always been inspired by his pioneering approach as an entrepreneur. —> Read More Here
Blast off! Researchers reveal rocket powered by POOP powerful enough to bring astronauts back from the moon
Florida Researchers have been working with Nasa to develop a system to repurpose human waste on a moonbase and turn it into fuel. —> Read More Here
Battiston said the Thales concerns were legitimate, but overblown. He outlined Italy’s position going into the ministerial conference, and the status of Cosmo-SkyMed.
A new study looks at the future of the Canadian Arctic Archipelago and finds that by the end of this century, the region might be ice-free for 2 to 5 months, something that puts bears in grave peril.
Public health groups say lower levels will benefit people who suffer from asthma or other respiratory illnesses. Business groups say it’s another expensive hoop to jump through.
The number of Americans getting and dying from colorectal cancer has been dropping steadily except for one group — younger adults.
Few fact-based dramas escape criticism of historical inaccuracy, and “The Imitation Game” is no exception. Based on the life of Alan Turing (Benedict Cumberbatch), the mathematician who broke the Nazi’s Enigma Code during World War II, effectively changing the course of the war, “The Imitation Game” has been under fire since June for its depiction of Turing’s homosexuality and his relationship with Joan Clarke. But Keira Knightley, who plays Clarke — Turing’s fiancée and fellow code-breaker — in the film, has had no shame in admitting to the various discrepancies between real life and the finished feature.
“As far as her relationship with Alan, they were engaged. They were great, great friends. She was at the center of the breaking of the Enigma Code,” Knightley told HuffPost Entertainment during an interview in October. Yet the actress admitted flat out that things had to be changed for various reasons. “There are a lot of inaccuracies in the film as to life. What was actually said, and the reasons that they actually got engaged, I think are slightly different than the film,”
Knightley, 29, said that the focus of “The Imitation Game” was the story behind cracking the code, not —> Read More Here